The US Food and Drug Administration gave emergency use authorization for booster doses of Pfizer/BioNTech’s Covid-19 vaccine for children ages 12 to 15 Monday.
The US Food and Drug Administration gave emergency use authorization for booster doses of Pfizer/BioNTech’s Covid-19 vaccine for children ages 12 to 15 Monday.